recent articles

Visiopharm today announces that it will be entering into a research pilot with Massachusetts General Hospital (MGH) to investigate the use of AI-powered precision pathology solutions for quality assurance of immunohistochemistry (IHC)...

Courtesy of Dark Daily: Pathologists will be interested to learn that researchers at Harvard Medical School and Massachusetts General Hospital are developing a “liquid biopsy” technology specifically to enable point-of-care...

OR

platinum partners

gold partners

Silver Partners

Media Partners